Rigel Pharmaceuticals Inc (FRA:RI2)
€ 33.87 -0.66 (-1.91%) Market Cap: 651.15 Mil Enterprise Value: 603.10 Mil PE Ratio: 2.46 PB Ratio: 1.85 GF Score: 24/100

Rigel Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 14, 2026 / 02:30PM GMT
Release Date Price: €27.04 (+1.16%)
Raul Rodriguez
Rigel Pharmaceuticals Inc - President, Chief Executive Officer, Director

Good morning. I am Raul Rodriguez, and I am the President and Chief Executive Officer and a member of the Board of Directors of Rigel Pharmaceuticals. I am very happy to welcome you to our 2026 annual meeting of stockholders of Rigel Pharmaceuticals.

As we are hosting today's meeting through a virtual online platform, stockholders who are attending this meeting with a valid 16-digit control number will have the opportunity to submit questions or comments during the Q&A portion of this meeting through the text box located on your screen. We will try to answer any such questions submitted that are germane to the proposals. Please submit your questions now to make sure they are received in a timely manner for our review and response.

(inaudible) on Thursday, May 14, 2026, and the polls are open for voting on all matters to be presented. The polls will be closed to voting after I go through each of the proposals to be voted on. If you intend to vote and have not already done so, you must submit your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot